Some oncogenes influence the fate of stem cells: LMO2, BCR-ABLp190, and BCR-ABLp210 are specifically associated with and drive human T acute lymphoblastic, B acute lymphoblastic leukemia, and chronic myeloid leukemia (CML), respectively. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.